Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO
Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPOView Video
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant
Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plantView Video

Latest Share Chat

Directorate Change

20 May 2019 10:41

RNS Number : 5568Z
Assura PLC
20 May 2019
 

 

20 May 2019

 

Assura plc

 

Directorate Changes

 

Assura plc ("Assura" or the "Company"), the leading investor and developer of primary care properties, announces that David Richardson intends to retire as Non-Executive Director of the Company at the conclusion of the AGM on 2 July 2019. David was appointed in 2012 and served as Chair of the Audit Committee and Senior Independent Director. 

David indicated to the Board last year that he was considering retiring after seven years in the role. Accordingly, the Board initiated a search for a new non-executive director, who could provide possible succession for David and Jonathan Davies joined the board in June last year as a Non-Executive Director. The Board now intends to appoint Jonathan as Chairman of the Audit Committee and Senior Independent Director at the AGM. 

Ed Smith, Non-Executive Chairman, commented; "I would like to thank David on behalf of our shareholders and the Board for his fantastic contribution to Assura over 7 years. His experience and wisdom have been invaluable in ensuring strong growth in our business and sound Governance and we wish him well in his retirement from our Board." 

David Richardson commented; " It has been a pleasure to serve on the Board of Assura. The journey from a small company to a FTSE 250 one has been exciting and I am retiring happy in the knowledge that the Company has a strong Board and management team and that its finances and strategy are sound."

- Ends -

 

For more information, please contact:

 

Assura plc

 

Tel: 01925 420660

Orla Ball

David Purcell

 

Finsbury

 

Tel: 0207 251 3801

Gordon Simpson

 

 

Notes to Editors

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create outstanding spaces for health services in our communities. At 30 September 2018, Assura's property portfolio was valued at £1,843 million.

 

 

Further information is available at www.assuraplc.com

 

*EPRA is a registered trademark of the European Public Real Estate Association.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
BOAPGURWAUPBUBU

Related Shares

Back to RNS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.